Position in IMVT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,951,513
+$1,879,872 QoQ
Shares Held
206,372
-15.6% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#46
of 226 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Granahan Investment Management, LLC holds $259,488,707 across 26 Biotechnology names. IMVT ranks #11 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
147,231 | $46,538,246 | |
| 2 | TWST |
Twist Bioscience Corp
|
314,882 | $32,395,060 | |
| 3 | CELC |
Celcuity Inc.
|
179,053 | $18,732,524 | |
| 4 | STOK |
Stoke Therapeutics, Inc.
|
461,608 | $15,103,813 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
446,988 | $9,771,157 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
83,270 | $9,245,468 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
163,759 | $9,006,745 | |
| 8 | TSHA |
Taysha Gene Therapies, Inc.
|
1,305,177 | $8,888,255 |
All Filings in IMVT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,951,513 | 206,372 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,071,641 | 244,430 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,851,378 | 230,188 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,291,482 | 266,221 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,409,408 | 213,088 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,944,880 | 172,316 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,700,538 | 149,396 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||